Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
GelSight provides extremely detailed and rapid surface measurements through the novel GelSight sensor technology.
etherna develops mRNA and lipid nanoparticle solutions.
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Thankful is a Developer of an automation software created to improve online customer service.
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Omega Funds has invested in 82 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Omega Funds's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 26 different industry categories.
Among tracked funding rounds, Alumis received $345.1M in a Post Ipo Equity round. Omega Funds's total known invested capital is $7.9B.
Omega Funds's average investment size is $96.5M across its portfolio of 82 companies.
Recent Omega Funds portfolio additions include Eyebiotech, Alpine Immune Sciences, Kezar Life Sciences, Photys Therapeutics, GelSight. These companies were founded in 2020 or later.